Skip to content
10-K

Annual Report

ARCUTIS BIOTHERAPEUTICS, INC. ARQT

0001787306-26-000018

← back to feed
Filed
Feb 25, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 20, 2026 124.03M sh
Shares Diluted FY 2025 · Dec 31, 2025 127.23M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 120.96M sh
Shares Diluted restated FY 2025 · Dec 31, 2023 69.31M sh
Capex FY 2025 · Dec 31, 2025 $686K
Capex FY 2025 · Dec 31, 2024 $143K
Capex FY 2025 · Dec 31, 2023 $428K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$5.63M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$112.16M
Operating Cash Flow FY 2025 · Dec 31, 2023 −$247.06M
Long Term Debt FY 2025 · Dec 31, 2025 $107.96M
Long Term Debt FY 2025 · Dec 31, 2024 $107.2M
Short Term Debt FY 2025 · Dec 31, 2025 $1M
Short Term Debt FY 2025 · Dec 31, 2024 $0
Cash And Equivalents FY 2025 · Dec 31, 2025 $42.91M
Cash And Equivalents FY 2025 · Dec 31, 2024 $71.34M
Stockholders Equity FY 2025 · Dec 31, 2025 $189.48M
Stockholders Equity FY 2025 · Dec 31, 2024 $157.54M
Stockholders Equity FY 2025 · Dec 31, 2023 $88.67M
Stockholders Equity FY 2025 · Dec 31, 2022 $209.58M
Current Liabilities FY 2025 · Dec 31, 2025 $129.84M
Current Liabilities FY 2025 · Dec 31, 2024 $81.01M
Total Liabilities FY 2025 · Dec 31, 2025 $243.49M
Total Liabilities FY 2025 · Dec 31, 2024 $191.35M
Current Assets FY 2025 · Dec 31, 2025 $411.23M
Current Assets FY 2025 · Dec 31, 2024 $335.82M
Total Assets FY 2025 · Dec 31, 2025 $432.97M
Total Assets FY 2025 · Dec 31, 2024 $348.89M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.13
Eps Diluted FY 2025 · Dec 31, 2024 −$1.16
Eps Diluted FY 2025 · Dec 31, 2023 −$3.78
Eps Basic FY 2025 · Dec 31, 2025 −$0.13
Eps Basic FY 2025 · Dec 31, 2024 −$1.16
Eps Basic FY 2025 · Dec 31, 2023 −$3.78
Sga Expense FY 2025 · Dec 31, 2025 $274.55M
Sga Expense FY 2025 · Dec 31, 2024 $229.39M
Sga Expense FY 2025 · Dec 31, 2023 $185.15M
Rd Expense FY 2025 · Dec 31, 2025 $77.05M
Rd Expense FY 2025 · Dec 31, 2024 $76.42M
Rd Expense FY 2025 · Dec 31, 2023 $110.58M
Net Income FY 2025 · Dec 31, 2025 −$16.14M
Net Income FY 2025 · Dec 31, 2024 −$140.04M
Net Income FY 2025 · Dec 31, 2023 −$262.14M
Operating Income FY 2025 · Dec 31, 2025 −$12.23M
Operating Income FY 2025 · Dec 31, 2024 −$128.4M
Operating Income FY 2025 · Dec 31, 2023 −$241.1M
Cost Of Revenue FY 2025 · Dec 31, 2025 $36.7M
Cost Of Revenue FY 2025 · Dec 31, 2024 $19.13M
Cost Of Revenue FY 2025 · Dec 31, 2023 $4.99M
Revenue FY 2025 · Dec 31, 2025 $376.07M
Revenue FY 2025 · Dec 31, 2024 $196.54M
Revenue FY 2025 · Dec 31, 2023 $59.61M